$LJPC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LA JOLLA PHARMACEUTICAL CO. Get notifications about new insider transactions in LA JOLLA PHARMACEUTICAL CO for free.
Page: < prev 1 2 3 4 5 6 7 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 10.88 | 112 | 1,219 | 1,281,172 | 1.3 M to 1.3 M (+0.01 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 10.88 | 112 | 1,219 | 1,281,172 | 1.3 M to 1.3 M (+0.01 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 12.80 | 70 | 896 | 70 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 12.80 | 70 | 896 | 70 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 10.88 | 70 | 762 | 74,633 | 74.6 K to 74.6 K (+0.09 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 10.88 | 70 | 762 | 74,633 | 74.6 K to 74.6 K (+0.09 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 12.80 | 108 | 1,382 | 108 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 12.80 | 108 | 1,382 | 108 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 10.88 | 108 | 1,175 | 6,968 | 6.9 K to 7 K (+1.57 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 10.88 | 108 | 1,175 | 6,968 | 6.9 K to 7 K (+1.57 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 14.47 | 26 | 376 | 26 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 14.47 | 26 | 376 | 26 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 12.30 | 26 | 320 | 594 | 568 to 594 (+4.58 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 12.30 | 26 | 320 | 594 | 568 to 594 (+4.58 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 14.47 | 63 | 912 | 63 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 14.47 | 63 | 912 | 63 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 12.30 | 63 | 775 | 74,563 | 74.5 K to 74.6 K (+0.08 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 12.30 | 63 | 775 | 74,563 | 74.5 K to 74.6 K (+0.08 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 14.47 | 100 | 1,447 | 100 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 14.47 | 100 | 1,447 | 100 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 12.30 | 100 | 1,230 | 1,281,060 | 1.3 M to 1.3 M (+0.01 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 12.30 | 100 | 1,230 | 1,281,060 | 1.3 M to 1.3 M (+0.01 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 14.47 | 16 | 232 | 16 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 14.47 | 16 | 232 | 16 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 12.30 | 16 | 197 | 2,147 | 2.1 K to 2.1 K (+0.75 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 12.30 | 16 | 197 | 2,147 | 2.1 K to 2.1 K (+0.75 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 14.47 | 96 | 1,389 | 96 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 14.47 | 96 | 1,389 | 96 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 12.30 | 96 | 1,181 | 6,860 | 6.8 K to 6.9 K (+1.42 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 12.30 | 96 | 1,181 | 6,860 | 6.8 K to 6.9 K (+1.42 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 14.90 | 97 | 1,445 | 97 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 12.67 | 97 | 1,229 | 1,280,960 | 1.3 M to 1.3 M (+0.01 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 14.90 | 61 | 909 | 61 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 12.67 | 61 | 773 | 74,500 | 74.4 K to 74.5 K (+0.08 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 14.90 | 24 | 358 | 24 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 12.67 | 24 | 304 | 568 | 544 to 568 (+4.41 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 14.90 | 94 | 1,401 | 94 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 12.67 | 94 | 1,191 | 6,764 | 6.7 K to 6.8 K (+1.41 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 14.90 | 16 | 238 | 16 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 12.67 | 16 | 203 | 2,131 | 2.1 K to 2.1 K (+0.76 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.30 | 56 | 913 | 56 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.30 | 56 | 913 | 56 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.86 | 56 | 776 | 74,439 | 74.4 K to 74.4 K (+0.08 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.86 | 56 | 776 | 74,439 | 74.4 K to 74.4 K (+0.08 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 16.30 | 85 | 1,386 | 85 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 16.30 | 85 | 1,386 | 85 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 13.86 | 85 | 1,178 | 6,670 | 6.6 K to 6.7 K (+1.29 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 13.86 | 85 | 1,178 | 6,670 | 6.6 K to 6.7 K (+1.29 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 16.30 | 15 | 245 | 15 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 16.30 | 15 | 245 | 15 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 13.86 | 15 | 208 | 2,115 | 2.1 K to 2.1 K (+0.71 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 13.86 | 15 | 208 | 2,115 | 2.1 K to 2.1 K (+0.71 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 16.30 | 89 | 1,451 | 89 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 16.30 | 89 | 1,451 | 89 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 13.86 | 89 | 1,233 | 1,280,863 | 1.3 M to 1.3 M (+0.01 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 13.86 | 89 | 1,233 | 1,280,863 | 1.3 M to 1.3 M (+0.01 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.30 | 22 | 359 | 22 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.30 | 22 | 359 | 22 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.86 | 22 | 305 | 544 | 522 to 544 (+4.21 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.86 | 22 | 305 | 544 | 522 to 544 (+4.21 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.25 | 22 | 358 | 22 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.25 | 22 | 358 | 22 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.81 | 22 | 304 | 522 | 500 to 522 (+4.40 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.81 | 22 | 304 | 522 | 500 to 522 (+4.40 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 16.25 | 15 | 244 | 15 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 16.25 | 15 | 244 | 15 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 13.81 | 15 | 207 | 2,100 | 2.1 K to 2.1 K (+0.72 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 13.81 | 15 | 207 | 2,100 | 2.1 K to 2.1 K (+0.72 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.25 | 55 | 894 | 55 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.25 | 55 | 894 | 55 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.81 | 55 | 760 | 74,383 | 74.3 K to 74.4 K (+0.07 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.81 | 55 | 760 | 74,383 | 74.3 K to 74.4 K (+0.07 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 16.25 | 88 | 1,430 | 88 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 16.25 | 88 | 1,430 | 88 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 13.81 | 88 | 1,215 | 1,280,774 | 1.3 M to 1.3 M (+0.01 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 13.81 | 88 | 1,215 | 1,280,774 | 1.3 M to 1.3 M (+0.01 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 16.25 | 85 | 1,381 | 85 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 16.25 | 85 | 1,381 | 85 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 13.81 | 85 | 1,174 | 6,585 | 6.5 K to 6.6 K (+1.31 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 13.81 | 85 | 1,174 | 6,585 | 6.5 K to 6.6 K (+1.31 %) |
| Aug 20 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 22.00 | 1,000 | 21,997 | 74,328 | 73.3 K to 74.3 K (+1.36 %) |
| Aug 20 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 22.00 | 1,000 | 21,997 | 74,328 | 73.3 K to 74.3 K (+1.36 %) |
| Aug 20 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 20.90 | 1,000 | 20,895 | 6,500 | 5.5 K to 6.5 K (+18.18 %) |
| Aug 20 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 20.90 | 1,000 | 20,895 | 6,500 | 5.5 K to 6.5 K (+18.18 %) |
| Jun 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | M | 6.00 | 500 | 3,000 | 13,500 | |
| Jun 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | M | 6.00 | 500 | 3,000 | 13,500 | |
| Jun 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Buy | M | 6.00 | 500 | 3,000 | 500 | 0 to 500 |
| Jun 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Buy | M | 6.00 | 500 | 3,000 | 500 | 0 to 500 |
| Mar 26 2018 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 29.50 | 700,000 | 20,650,000 | 4,313,611 | 3.6 M to 4.3 M (+19.37 %) |
| Mar 19 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 29.50 | 508,474 | 14,999,983 | 4,138,893 | 3.6 M to 4.1 M (+14.01 %) |
| Mar 02 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 30.44 | 10,000 | 304,435 | 3,630,419 | 3.6 M to 3.6 M (+0.28 %) |
| Mar 02 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 30.15 | 10,000 | 301,540 | 3,620,419 | 3.6 M to 3.6 M (+0.28 %) |
| Mar 02 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 30.12 | 10,000 | 301,171 | 3,610,419 | 3.6 M to 3.6 M (+0.28 %) |
| Mar 02 2018 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 29.54 | 10,000 | 295,381 | 3,600,419 | 3.6 M to 3.6 M (+0.28 %) |
| Feb 27 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 32.48 | 1,000 | 32,475 | 5,500 | 4.5 K to 5.5 K (+22.22 %) |
| Feb 20 2018 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 32.42 | 50,000 | 1,621,000 | 3,613,611 | 3.6 M to 3.6 M (+1.40 %) |
| Feb 15 2018 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 32.69 | 100,000 | 3,269,000 | 3,563,611 | 3.5 M to 3.6 M (+2.89 %) |
| Feb 15 2018 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 32.75 | 75,000 | 2,456,250 | 3,463,611 | 3.4 M to 3.5 M (+2.21 %) |
| Jan 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | M | 6.00 | 4,000 | 24,000 | 14,000 | |
| Jan 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | M | 10.84 | 6,000 | 65,040 | 0 | |
| Jan 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Sell | S | 32.32 | 10,000 | 323,208 | 0 | 10 K to 0 (-100.00 %) |
| Jan 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Buy | M | 6.00 | 4,000 | 24,000 | 10,000 | 6 K to 10 K (+66.67 %) |
| Jan 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Buy | M | 10.84 | 6,000 | 65,040 | 6,000 | 0 to 6 K |
| Dec 29 2017 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 33.22 | 1,000 | 33,215 | 4,500 | 3.5 K to 4.5 K (+28.57 %) |
| Dec 29 2017 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 32.47 | 6,700 | 217,549 | 6,700 | |
| Dec 29 2017 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 32.47 | 6,700 | 217,549 | 6,700 | |
| Dec 29 2017 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 32.47 | 6,700 | 217,549 | 6,700 | |
| Dec 29 2017 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 32.47 | 25,000 | 811,750 | 25,000 | |
| Dec 29 2017 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 32.47 | 6,700 | 217,549 | 6,700 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 28.10 | 49,000 | 1,376,900 | 49,000 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 28.10 | 49,000 | 1,376,900 | 49,000 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 28.10 | 10,000 | 281,000 | 10,000 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 28.10 | 49,000 | 1,376,900 | 49,000 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | Rosen Robert | Director | Option Exercise | A | 28.10 | 10,000 | 281,000 | 10,000 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 28.10 | 183,000 | 5,142,300 | 183,000 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | A | 28.10 | 10,000 | 281,000 | 10,000 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 28.10 | 49,000 | 1,376,900 | 49,000 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 28.10 | 10,000 | 281,000 | 10,000 | |
| Mar 27 2017 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 33.50 | 149,254 | 5,000,009 | 3,440,419 | 3.3 M to 3.4 M (+4.53 %) |
| Mar 06 2017 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 34.15 | 1,000 | 34,150 | 1,354,086 | 1.4 M to 1.4 M (+0.07 %) |
| Mar 06 2017 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 34.18 | 2,000 | 68,355 | 1,353,086 | 1.4 M to 1.4 M (+0.15 %) |
| Mar 06 2017 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 34.44 | 300 | 10,331 | 3,500 | 3.2 K to 3.5 K (+9.38 %) |
| Mar 06 2017 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 34.45 | 300 | 10,334 | 3,200 | 2.9 K to 3.2 K (+10.34 %) |
| Mar 06 2017 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 34.49 | 400 | 13,796 | 2,900 | 2.5 K to 2.9 K (+16.00 %) |
| Mar 06 2017 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Buy | P | 34.48 | 1,000 | 34,480 | 2,085 | 1.1 K to 2.1 K (+92.17 %) |
| Mar 06 2017 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Buy | P | 35.33 | 600 | 21,198 | 1,085 | 485 to 1.1 K (+123.71 %) |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 19.19 | 214,700 | 4,120,093 | 214,700 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 19.19 | 64,100 | 1,230,079 | 64,100 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 19.19 | 64,100 | 1,230,079 | 64,100 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | A | 19.19 | 10,000 | 191,900 | 10,000 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 19.19 | 10,000 | 191,900 | 10,000 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | Rosen Robert | Director | Option Exercise | A | 19.19 | 10,000 | 191,900 | 10,000 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 19.19 | 64,100 | 1,230,079 | 64,100 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 19.19 | 64,100 | 1,230,079 | 64,100 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 19.19 | 10,000 | 191,900 | 10,000 | |
| Dec 30 2016 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Gift | G | 0.00 | 74,000 | 0 | 1,351,086 | 1.4 M to 1.4 M (-5.19 %) |
| Sep 13 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 20.28 | 16,448 | 333,514 | 3,191,165 | 3.2 M to 3.2 M (+0.52 %) |
| Sep 13 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 19.92 | 22,587 | 449,886 | 3,174,717 | 3.2 M to 3.2 M (+0.72 %) |
| Sep 13 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 19.72 | 100,000 | 1,971,970 | 3,152,130 | 3.1 M to 3.2 M (+3.28 %) |
| Mar 08 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 19.85 | 20,000 | 396,928 | 3,052,130 | 3 M to 3.1 M (+0.66 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.93 | 20,000 | 378,560 | 3,032,130 | 3 M to 3 M (+0.66 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.55 | 20,000 | 370,906 | 3,012,130 | 3 M to 3 M (+0.67 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.72 | 20,000 | 374,488 | 2,992,130 | 3 M to 3 M (+0.67 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.91 | 13,500 | 255,280 | 2,972,130 | 3 M to 3 M (+0.46 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.77 | 6,500 | 121,985 | 2,958,630 | 3 M to 3 M (+0.22 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 18.08 | 20,000 | 361,528 | 2,952,130 | 2.9 M to 3 M (+0.68 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 17.86 | 4,028 | 71,926 | 2,932,130 | 2.9 M to 2.9 M (+0.14 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 16.94 | 15,972 | 270,598 | 2,928,102 | 2.9 M to 2.9 M (+0.55 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 16.13 | 20,000 | 322,502 | 2,912,130 | 2.9 M to 2.9 M (+0.69 %) |
| Mar 03 2016 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 16.19 | 20,000 | 323,714 | 2,892,130 | 2.9 M to 2.9 M (+0.70 %) |